Stephen Hanauer is a Gastroenterology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 N Saint Clair St Ste 650
Chicago, IL 606112929
Telephone
312-695-5620Registry record last updated 23 May 2017.
Clinical trials
- Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Sponsor: Northwestern University
- Treating Chronic Pouchitis With a Low FODMAP Diet
Sponsor: Northwestern University
- To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202564 payments$88,575openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202544 payments$66,258openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202530 payments$42,897openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
54.5%Aminosalicylate30.1%Mesalamine72%Sulfasalazine12%Mesalamine Dr8%Mesalamine Er8%Part D<11 patientsProton pump inhibitor9.5%Pantoprazole Sodium41%Omeprazole36%Esomeprazole Magnesium24%Part D<11 patients+ 4 more classes in this area
Cancer & immunology
30%TNF inhibitor10.1%Humira(Cf) Pen100%Part D<11 patientsInterleukin-12 Antagonist6.7%Stelara100%Part D<11 patients+ 4 more classes in this area
Respiratory
6.7%Corticosteroid6.7%Budesonide Dr60%Budesonide Ec41%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1993–2004 per NIH RePORTER. The latest:
- Multi-site Trial of Azathioprine Dosing in Crohn Disease
University of Chicago
FY2004$743,793U01DK060083 - Multi-site Trial of Azathioprine Dosing in Crohn Disease
University of Chicago
FY2003$762,331R01DK060083
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”